Asia-Pacific Nuclear Imaging Market by Diagnostic Technologies (PET Radioisotopes-(Rubidium-82, Fluorine-18, and Others), SPECT Radioisotopes-(Thallium-201, Technetium-99m, Xenon-133, Iodine-123, and Others)), by Application (PET-(Cardiology, Oncology, Neurology, and Others), SPECT-(Lymphoma, Neurology, Cardiology, Thyroid, and Others)) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Nuclear Imaging Market by Diagnostic Technologies (PET Radioisotopes-(Rubidium-82, Fluorine-18, and Others), SPECT Radioisotopes-(Thallium-201, Technetium-99m, Xenon-133, Iodine-123, and Others)), by Application (PET-(Cardiology, Oncology, Neurology, and Others), SPECT-(Lymphoma, Neurology, Cardiology, Thyroid, and Others)) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1626 | Pages: 138 | November 2016 | Region: Asia Pacific


The Asia-Pacific Nuclear Imaging Market was worth $3.13 billion in 2016 and estimated to be growing at a CAGR of 9.64%, to reach $4.96 billion by 2021. Medical imaging is the method of generating a photographic image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.

Nuclear imaging is most commonly utilized for cardiovascular and oncology applications. It refers to the method of generating visuals of the organs of the body by processing minor quantity of radioactive tracers. The images are obtained using a gamma camera and can be documented on film or on a computer.

The growth of the Asia-Pacific Nuclear Imaging market is mainly due to factors such as an increase in the number of cancer and cardiovascular disease cases, predilection towards minimally invasive procedures, ready availability of radiopharmaceuticals, and improving healthcare infrastructure in developing markets. However, factors such as costly procedures & equipment, inadequate number of trained medical staff, and shortage of supplies are hampering the growth of the market in this region.

The Asia-Pacific Nuclear Imaging market is segmented based on Diagnostic Technologies and Application. The market for Nuclear Imaging, on the basis of Diagnostic Technologies is segmented into PET Radioisotopes and SPECT Radioisotopes. PET Radioisotopes are further segmented into Rubidium-82, Fluorine-18, whereas SPECT Radioisotopes are further segmented into Thallium-201, Technetium-99m, Xenon-133, and Iodine-123. On the basis of Application, the Nuclear Imaging market is segmented into PET and SPECT. PET is further segmented into Cardiology, Oncology, and Neurology, whereas SPECT is segmented into Lymphoma, Neurology, Cardiology, and Thyroid. PET is mainly being utilized in oncology due to superior quality of imaging; Whereas SPECT is used in the cardiology section accounting for almost 80% of the entire cardiology market share.

The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Among Asia-Pacific countries, India, Japan, and Australia will be the substantial markets due to growing healthcare budgets and rising popularity of several radiopharmaceuticals in numerous clinical indications.

Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution. The major companies dominating the Nuclear Imaging market in this region are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Technologies                        

                                5.1.1 Introduction           

                                5.1.2 PET Radioisotopes

                                                5.1.2.1 Rubidium-82

                                                5.1.2.2 Fluorine-18

                                                5.1.2.3 Others

                                5.1.3 SPECT Radioisotopes          

                                                5.1.3.1 Thallium-201

                                                5.1.3.2 Technetium-99m

                                                5.1.3.3 Xenon-133

                                                5.1.3.4 Iodine-123

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Diagnostic Technologies                

                                5.1.5 Market Attractiveness Analysis, By Diagnostic Technologies              

                                5.1.6 Market Share Analysis, By Diagnostic Technologies               

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 PET             

                                                5.2.2.1 Cardiology

                                                5.2.2.2 Oncology

                                                5.2.2.3 Neurology

                                                5.2.2.4 Others

                                5.2.3 SPECT        

                                                5.2.3.1 Lymphoma

                                                5.2.3.2 Neurology

                                                5.2.3.3 Cardiology

                                                5.2.3.4 Thyroid

                                                5.2.3.5 Others

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application        

                                5.2.6 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Technologies

                                                6.1.3.3 By Application

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Technologies

                                                6.1.4.3 By Application

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Technologies

                                                6.1.5.3 By Application

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Mallinckrodt plc                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Siemens Medical Solutions                  

                8.3 Hitachi Medical Corporation               

                8.4 Medtronic Inc.                          

                8.5 General Electric Co. (healthcare division)                       

                8.6 IBA Group                   

                8.7 Positron Corporation                              

                8.8 Philips Medical Systems                        

                8.9 Naviscan                      

                8.10 Toshiba Medical Systems Corporation                          

                8.11 Carestream Health                

                8.12 Lantheus Medical Imaging Inc.                         

                8.13 Cardinal Health Inc.                              

                8.14 Bayer AG                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Nuclear Imaging Market By Region, From 2016-2021 (USD Billion)
  2. Asia-Pacific Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  3. Asia-Pacific PET Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  4. Asia-Pacific Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  5. Asia-Pacific Rubidium-82 Market By Region, From 2016-2021 (USD Billion)
  6. Asia-Pacific Fluorine-18 Market By Region, From 2016-2021 (USD Billion)
  7. Asia-Pacific Other PET radioisotopes Market By Region, From 2016-2021 (USD Billion)
  8. Asia-Pacific SPECT Radioisotopes Market By Region, From 2016-2021 (USD Billion)
  9. Asia-Pacific Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  10. Asia-Pacific Thallium-201 Market By Region, From 2016-2021 (USD Billion)
  11. Asia-Pacific Technetium-99m Market By Region, From 2016-2021 (USD Billion)
  12. Asia-Pacific Xenon-133 Market By Region, From 2016-2021 (USD Billion)
  13. Asia-Pacific Iodine-123 Market By Region, From 2016-2021 (USD Billion)
  14. Asia-Pacific Other SPECT radioisotopes Market By Region, From 2016-2021 (USD Billion)
  15. Asia-Pacific Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  16. Asia-Pacific PET Market By Region, From 2016-2021 (USD Billion)
  17. Asia-Pacific Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  18. Asia-Pacific Cardiology Market By Region, From 2016-2021 (USD Billion)
  19. Asia-Pacific Oncology Market By Region, From 2016-2021 (USD Billion)
  20. Asia-Pacific Neurology Market By Region, From 2016-2021 (USD Billion)
  21. Asia-Pacific Other PET applications Market By Region, From 2016-2021 (USD Billion)
  22. Asia-Pacific SPECT Market By Region, From 2016-2021 (USD Billion)
  23. Asia-Pacific Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  24. Asia-Pacific Lymphoma Market By Region, From 2016-2021 (USD Billion)
  25. Asia-Pacific Neurology Market By Region, From 2016-2021 (USD Billion)
  26. Asia-Pacific Cardiology Market By Region, From 2016-2021 (USD Billion)
  27. Asia-Pacific Thyroid Market By Region, From 2016-2021 (USD Billion)
  28. Asia-Pacific Other SPECT applications Market By Region, From 2016-2021 (USD Billion)
  29. China Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  30. China Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  31. China Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  32. China Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  33. China Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  34. China Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  35. India Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  36. India Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  37. India Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  38. India Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  39. India Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  40. India Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  41. Japan Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  42. Japan Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  43. Japan Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  44. Japan Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  45. Japan Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  46. Japan Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  47. South Korea Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  48. South Korea Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  49. South Korea Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  50. South Korea Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  51. South Korea Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  52. South Korea Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
  53. Australia Nuclear Imaging Market By Diagnostic Technologies , From 2016-2021 (USD Billion)
  54. Australia Nuclear Imaging Market By PET Radioisotopes, From 2016-2021 (USD Billion)
  55. Australia Nuclear Imaging Market By SPECT Radioisotopes, From 2016-2021 (USD Billion)
  56. Australia Nuclear Imaging Market By Application, From 2016-2021 (USD Billion)
  57. Australia Nuclear Imaging Market By PET, From 2016-2021 (USD Billion)
  58. Australia Nuclear Imaging Market By SPECT, From 2016-2021 (USD Billion)
Middle East And Africa Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU,...
Latin America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Asia Pacific Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Th...
Europe Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermogr...
North America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, O...
Middle East And Africa High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (T...
Latin America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
Asia Pacific High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Iden...
Europe High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identifica...
North America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identification, P...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.